FDA advisory panel backs letting compounders make peptides
The recommendation covers peptides that compounding pharmacies have been making for human use while their safety and efficacy evidence remains fragmented.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 24 18:16 ETSource: KFOR.com
The wire
- 01An FDA advisory panel recommended allowing compounding pharmacies to prepare peptides for human use, according to the report.
- 02Compounders, telehealth prescribers and clinicians have been operating in limbo while the agency reviewed a list of popular peptides for bulk compounding.
- 03Advisory panel recommendations are not binding; the FDA's final determination and any category placement for individual peptides are still to come.
From the source
Read at kfor.comFDA advisory panel allows compounding pharmacies to make peptides
